BioTuesdays

Category - Markets

Dova Pharmaceuticals
Markets

HCW starts Dova Pharma at buy; PT $18

H.C. Wainwright initiated coverage of Dova Pharmaceuticals (NASDAQ:DOVA) with a “buy” rating and price target of $18. The stock closed at $5.73 on Dec.19. Dova is developing a new thrombopoietin receptor alpha agonist...

December 21, 2018
DBV Technologies
Markets

Stifel cuts DBV Technologies to hold; PT $11

Stifel downgraded DBV Technologies (NASDAQ:DBVT) to “hold” from “buy” and slashed its price target to $11 from $35 after the company withdrew the BLA for its Viaskin peanut allergy treatment after a meeting with the FDA...

December 20, 2018
Brainstorm Cell Therapeutics Logo
Markets

Dawson James starts Brainstorm at buy; PT $12

Dawson James initiated coverage of Brainstorm (NASDAQ:BCLI) with a “buy” rating and $12 price target. The stock closed at $3.05 on Dec. 17. Brainstorm uses autologous cell therapy to treat amyotrophic lateral sclerosis...

December 18, 2018
GlycoMimetics
Markets

HCW starts GlycoMimetics at buy; PT $24

H.C. Wainwright launched coverage of GlycoMimetics (NASDAQ:GLYC) with a “buy” rating and $24 price target based on a positive outlook for the company’s pipeline. The stock closed at $10.29 on Dec. 17...

December 18, 2018
Novavax Logo
Markets

Ladenburg starts Novavax at buy; PT $3

Ladenburg Thalmann initiated coverage of Novavax (NASDAQ:NVAX) with a “buy” rating and $3 price target, as “we look for transformational data in the first quarter of 2019.” The stock closed at $2.27 on Dec. 17. Novavax...

December 18, 2018